Abstract
Both prevalence and incidence of genital HPV infections have significantly increased in most countries during the past 20 years (Powell 1978; Oriel 1981). The infection may cause a broad spectrum of characteristic dysplastic and neoplastic changes of the target tissue. Specific PV types have predilections for particular anatomical sites and tissues, affecting predominantly the different squamous epithelia of the anogenital area, the vagina, and both the original and metaplastic squamous epithelium of the uterine cervix. In metaplastic epithelium the proliferating cells susceptible to the infectious agent are superficially located. Thus, the immature transformation zone is the preferred target of HPV and other exogenous noxa, whereas in original squamous epithelium the compartment of mitotic active basal cells is protected by several rows of differentiating cells, and the susceptible cells can be reached only through epithelial defects and ulcerations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abell MR, Gosling G jr (1961) Intraepithelial and infiltrative carcinoma of the vulva: Bowen’s type. Cancer 14: 318–329
Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H (1984) A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines from cervical cancer. EMBO J 3: 1151–1157
Burk RD, Kadish AS, Calderin S, Romney SL (1986) Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 154: 982–989
Burke L (1982) The use of carbon dioxide laser in the therapy of cervical intraepithelial neoplasia. Am J Obstet Gynecol 144: 337–340
Choo YC, Seto WH, Hsu C, Merigan TC, Tan YH, Ma HK, Ng NH (1986) Cervical intraepithelial neoplasia treated by perilesional injection of interferon. Br J Obstet Gynaecol 93: 372–379
Cole ST, Streek RE (1986) Genome organization and nucleotide sequence of humanpapillomavirus type 33, which is associated with cervical cancer. J Virol 58:991–995
Crum CP, Richart RM (1980) The out-patient approach to the patient with an abnormal Papanicolaou smear. In: Grundman E (ed) Cancer of the uterine cervix. Fischer, Stuttgart (Cancer campaign, vol 8 )
Della Torre G, Pilotti S, de Palo G, Rike F (1978) Viral particles in cervical condylomatous lesions. Tumori 64: 549–553
De Villiers EM, Schneider A, Gross G, zur Hausen H (1986) Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immuno1 174:281–286
Durst M, Kleinheinz A, Hotz M, Gissmann L (1985) The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumors. J Gen Virol 66: 1515–1525
Ferenczy A, Braun L, Shah KV (1981) Human papillomavirus (HPV) in condylomatous lesions of the cervix. Am J Surg Patho 15:661–670
Ferenczy A, Mitao M, Naga N, Silverstein SJ, Crum CP (1985) Latent papillomavirus and recurring genital warts. N Engl J Med 313: 784–788
Fu YS, Braun L, Shah KV, Lawrence W, Robboy S (1983) Histologic, nuclear DNA, and human papillomavirus studies of cervical condylomas. Cancer 52: 1705–1711
Fukushima M, Yamakawa Y, Shimano S, Hashimoto M, Sawada Y, Fujinaga K (1987) The physical state of the human papillomavirus type 16 (HPV 16) DNA in carcinoma of the uterine cervix. In: Lancaster WD, Jenson AB (eds) 6th International Papillomavirus Workshop. Georgetown University, Washington
Gall SA, Hughes CE, Mounts P, Segritti A, Weck PK, Whisnant JK (1986) Efficacy of human lymphoblastic interferon in the therapy of resistant condyloma acuminata. Obstet Gynecol 67: 643–651
Gross G, Hagedorn M, Ikenberg H (1985a) Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequence. Arch Dermatol 121: 858–863
Gross G, Schneider A, Hauser-Brauner B, Wagner D, Ikenberg H, Gissmann L (1985b) Transmission of genital papillomavirus infections: a study of sexual partners. J Cell Biochem [Suppl] 69: 71
Gross G, Roussaki A, Pfister H (1989) Recurrent vulvar Buschke-Löwenstein’s tumorlike condyloma acuminata and Hodgkin’s disease effectively treated with recombinant interferon a2c gel as adjuvant to electrosurgery. In: Fritsch P, Schuler G, Hintner H (eds) Immunodeficiency and skin. Karger, Basel, pp 178–184 (Current problems in dermatology, vol 18 )
Guillet G, Braun L, Shah KV, Ferenczy A (1983) Papillomavirus in cervical condylomas with and without associated cervical intraepithelial neoplasia. J Invest Dermatol 81: 513–516
Hatch GD (1989) Interferon treatment of human papillomavirus. Colposcopist 21: 1–4
Heinzl S (1981) Die Behandlung benigner und prämaligner Zervixveränderungen mit CO2-Laser. Gynäkologe 14: 245–251
Heinzl S (1988) Destructive methods in the treatment of cervical and vulval intraepithelial neoplasia. In: Stegner H-E, Coppleson M (eds) Colposcopy in diagnosis and treatment of preneoplastic lesions. Springer, Berlin Heidelberg New York
Hilgarth HH, Hillemanns G, Göppinger A (1988) Therapy of intraepithelial neoplasia. In: Stegner H-E, Coppleson M (eds) Colposcopy in diagnosis and treatment of preneoplastic lesions. Springer, Berlin Heidelberg New York
Hills E, Laverty CR (1979) Electron-microscope detection of papillomavirus particles in selected koilocytic cells in routine cervical smears. Acta Cyto 123:53–56
Ikenberg H, Gissmann L, Gross G, Grussendorf-Conen E, zur Hausen H (1983) Human papillomavirus type 16-related DNA in genital Bowen’s disease and in bowenoid papulosis. Int J Cancer 32: 563–565
Ikenberg H, Spitz C, Schworer D, Pfleiderer A (1987) Human papillomavirus DNA in genital carcinomas. Correlation with clinical stage, histology and clinical course of the disease. In: Lancaster WD, Jenson AB (eds) 6th International Papillomavirus Workshop. Georgetown University, Washington
Ikic D (1983) Intralesional therapy. In: Sikora K (ed) Interferon and cancer. Plenum Press, New York
Kirby P, Wells D, Kiviat N, Corey L (1986) A phase-I trial of intramuscular recom- binant gamma interferon for refractory genital warts. J Invest Dermatol 86: 485
Kurman RJ, Shah KV, Lancaster WD, Jenson AB (1982) Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas. Am J Obstet Gynecol 140: 931–935
Kurman RJ, Jenson AB, Lancaster WD (1983) Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins. Am J Surg Pathol 7: 39–52
Lorincz AT, Quinn AP, Lancaster WD, Temple GF (1987) A new type of papillomavirus associated with cancer of the uterine cervix. Virology 159: 187–190
MacNar JCM, Walkinshaw SA, Cordiner JW, Clements JB (1986) Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N Engl J Med 315: 1052–1058
McCance DJ, Campion MJ, Clarkson PK, Chesters RM, Jenkins D, Singer A (1985) Prevalence of human papillomavirus type 16 DNA sequences in cervical intraepithelial neoplasia and invasive carcinoma of the cervix. Br J Obstet Gynaecol 92: 1101–1105
Meisels A, Morin C, Casas-Cordero M (1982) Human papillomavirus infection of the uterine cervix. Int J Gynecol Pathol 1: 75–94
Morin C, Meisels A (1980) Human papillomavirus infection of the uterine cervix. Acta Cytol 24:82–84
Morin C, Braun L, Casas-Cordero M, Shah KV, Roy M, Fortier M, Meisels A (1981) Confirmation of the papillomavirus etiology of condylomatous cervical lesion by the peroxidase-antiperoxidase technique. JNCI 66: 831–835
Oriel JD (1981) Genital warts. Sex Transco Dis 8: 326–329
Powell L (1978) Condyloma acuminatum. Recent advances in development, carcinogenesis and treatment. Clin Obstet Gynecol 21: 1061–1079
Pratili MA, Ledoussal V, Harvey P, Laval C, Bertrand F, Jibard N, Croissant O, Orth G (1986) Human papillomavirus in the epithelial cells of the cervix uteri: frequency of types 16 and 18. Preliminary results of a clinical, cytologic and viral study. J Gynecol Obstet Biol Reprod (Paris) 15: 45–50
Reid R, Laverty CR, Coppleson M, Isarangkul W, Hills E (1980) Noncondylomatous cervical wart virus infection. Obstet Gynecol 55: 476–483
Sato S, Okagaki T, Clark BA, Twiggs LB, Fukushima M, Ostrow RS, Faras AJ (1987) Sensitivity of koilocytosis, immunocytochemistry, and electron microscopy as compared to DNA hybridization in detecting human papillomavirus in cervical and vaginal condyloma and intraepithelial neoplasia. Int J Gynecol Pathol 5: 297–307
Schneider A (1987) Morphologische und klinische Aspekte humaner Papillomavirus- Infektionen im unteren Genitaltrakt. Habilitationsschrift, University of Ulm
Schneider A, Schuhmann R, de Villiers E-M, Gissmann L (1986) Klinische Bedeutung von humanen Papillomavirus-(HPV)-Infektionen im unteren Genitaltrakt. Geburtshilfe Frauenheilkd 46: 261–266
Schonfeld A, Nitke S, Schattner A, Wallach D, Crespi M, Hahn T, Levavi H, Yarden O, Shoham J, Doerner T, Revel M (1984) Intramuscular human interferon-beta injections in treatment of condylomata acuminata. Lancet 1: 1038–1042
Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111–114
Seedorf K, Krämmer G, Dürst M, Suhai S, Röwekamp WG (1985) Human papillomavirus type 16 DNA sequence. Virology 145: 181–185
Singer A, Jordan JA (1978) The management of premalignant cervical disease. Clin Obstet Gynaecol 5: 629
Syrjänen KJ (1983) Human papillomavirus lesions in association with cervical dysplasias and neoplasias. Obstet Gynecol 62: 617–624
Tase T, Okagaki T, Clark BA, Twiggs LB, Ostrow RS, Faras AJ (1989) Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting squamous intraepithelial neoplasia. Int J Gynecol Pathol 8: 8–17
Wade TR, Kopf AW, Ackerman AB (1979) Bowenoid papulosis of the genitalia. Arch Dermatol 115: 306–308
Wagner D, Ikenberg H, Boehm N, Gissmann L (1984) Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization. Obstet Gynecol 64: 767–772
Warhol MJ, Pinkus GS, Rice RH, El-Tawil GH, Lancaster WD, Jenson AB, Kurman RJ (1984) Papillomavirus infection of the cervix. III. Relationship of the presence of viral structural proteins to the expression of involucrin. Int J Gynecol Pathol 3: 71–81
Wickenden C, Steele A, Malcolm AD, Coleman DV (1985) Screening for wart virus infection in normal and abnormal cervices by DNA hybridization of cervical scrapes. Lancet 1: 65–67
Woodruff JD, Braun L, Cavalieri R, Gupta P, Pass F, Shah KV (1980) Immunologic identification of papillomavirus antigen in condyloma tissues from the female genital tract. Obstet Gynecol 56: 727–732
Yoshikawa H, Matsukura T, Yamamoto E, Kawana T, Mizuno M, Yoshike K (1985) Occurrence of hunian papillomavirus type 16 and 18 DNA in cervical carcinomas from Japan: Age of patients and histological type of carcinomas. Gann 76: 667–671
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Stegner, HE. (1990). HPV Infection and Precancer in Gynaecology — Diagnosis and Therapeutic Aspects. In: Gross, G., Jablonska, S., Pfister, H., Stegner, HE. (eds) Genital Papillomavirus Infections. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75723-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-75723-5_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75725-9
Online ISBN: 978-3-642-75723-5
eBook Packages: Springer Book Archive